2022 annual financial data
Atrium Therapeutics 2022 Operating margin
Direct answer
Operating margin was -1,939.65%.
Operating income was -178,913,000 USD and net income was -169,077,000 USD.
Operating cash flow was -136,268,000 USD.
Get free Atrium Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 9,224,000 USD
- Operating income
- -178,913,000 USD
- Net income
- -169,077,000 USD
- Operating cash flow
- -136,268,000 USD